TP53 and breast carcinoma: In our national guidelines, annual breast MRI screening is recommended for most women with a known genetic predisposition for developing breast cancer, such as BRCA-1, BRCA-2, TP53, PALB2, CDH1, STK11, and PTEN gene mutations.